Viracta Therapeutics Inc

NASDAQ:VIRX 4:00:00 PM EDT

1.04

0.00 (0.00%)

4:51:30 PM EDT: $1.06 +0.02 (+1.92%)

Viracta Therapeutics Inc Stock, NASDAQ:VIRX

2533 South Coast Highway 101, Suite 210, Cardiff, California 92007

United States of America

Phone: +1.858.400.8470

Number of Employees: 32

http://www.viracta.com

Description

Viracta Therapeutics, Inc. a clinical-stage, biomarker-directed precision oncology company focused on new medicines for the treatment of virus-associated malignancies. It develops antiviral agent valganciclovir as an oral combination therapy which is in a Phase 2 clinical trial for EBV-positive lymphomas. The company was founded on February 10, 1998 and is headquartered in Cardiff, CA.